High-affinity T cell receptors for adoptive cell transfer

2Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Adoptive cell transfer (ACT) of engineered T cell receptors (TCRs) for cancer immunotherapy has evolved from simple gene transfer of isolated TCRs to various affinity enhancement techniques that overcome limitations imposed by central and peripheral tolerance on TCR affinity. In the current issue of the JCI, Poncette et al. used mice with human TCRαβ and HLA gene loci to discover CD4+ TCRs of optimal affinity for cancer testis antigen (CTA) NY-ESO-1. They combined this TCR with a previously discovered NY-ESO-1- specific CD8+ TCR in an ACT fibrosarcoma tumor model to demonstrate the importance of T cell help in mediating antitumor responses.

Cite

CITATION STYLE

APA

Isser, A., & Schneck, J. P. (2019, January 2). High-affinity T cell receptors for adoptive cell transfer. Journal of Clinical Investigation. American Society for Clinical Investigation. https://doi.org/10.1172/JCI125471

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free